Downs, R W <br/><br/>
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  May 2000 
 - 1783-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jcem.85.5.6606  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Administration, Intranasal<br/>Alendronate--adverse effects<br/>Alkaline Phosphatase--blood<br/>Biomarkers--blood<br/>Bone Density--drug effects<br/>Bone and Bones--metabolism<br/>Calcitonin--administration & dosage<br/>Collagen--urine<br/>Collagen Type I<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Peptides--urine<br/>Placebos